| Literature DB >> 31752200 |
Bahare Salehi1, Javad Sharifi-Rad2, Ana M L Seca3,4, Diana C G A Pinto4, Izabela Michalak5, Antonio Trincone6, Abhay Prakash Mishra7, Manisha Nigam7, Wissam Zam8, Natália Martins9,10.
Abstract
Seaweeds have received huge interest in recent years given their promising potentialities. Their antioxidant, anti-inflammatory, antiEntities:
Keywords: bioactivity; pharmaceutical and cosmetic applications; primary metabolites; seaweeds; secondary metabolites
Mesh:
Substances:
Year: 2019 PMID: 31752200 PMCID: PMC6891420 DOI: 10.3390/molecules24224182
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Average content of each seaweed primary metabolite class and minerals.
| Metabolites Classes | Green (Chlorophyta) | Brown (Ochrophyta) | Red (Rhodophyta) |
|---|---|---|---|
| Total Carbohydrates (% dw) | 29.8–58.1 [ | 12.2–56.4 [ | 34.6–71.2 [ |
| Minerals (ash,% dw) | 11–73% [ | 17–44% [ | 7–37% [ |
| Macrominerals (% dw) | 0.2–2.4 | 1.3–7.0 | 0.3–10 |
| Na | 1.1–2.8 | 0.9–11.5 | 0.2–9.2 |
| K | 0.09–4.9 | 0.4–3.0 | 0.2–1.9 |
| Ca | 0.4–3.7 | 0.1–1.2 | 0.1–1.7 |
| Mg | 0.09–0.25 | 0.07–0.4 | 0.1–0.7 |
| P | [ | [ | [ |
| Trace elements (mg/kg dw) | 98–5800 | 16–1854 | 366–2110 |
| Fe | 3.0–32.7 | 6.8–154 | 23–72 |
| Zn | 0.5–32.7 | 0.8–38.6 | 1.99–34.6 |
| Cu | 26–180 | 2.7–547 | 4.1–392 |
| Mn | 23–480 | 59–11096 | 22–340 |
| I | [ | [ | [ |
| Proteins (% dw) | 8.7–32.7 | 4.3–24.0 [ | 8.0–47.0 [ |
| Lipids (total lipids%, dw) | 0.2–4.1 [ | 0.3–4.5 [ | 0.12–3.8 [ |
| Saturated fatty acids (% of total fatty acid) | 34–77 | 20–50 | 25.5–76 |
| Mono-unsaturated fatty acids (% of total fatty acid) | 12.2–23 | 11–36 | 10.6–35.7 |
| Poly-unsaturated fatty acids (% of total fatty acid) | 6.6–39 | 20–67 | 12.1–68 |
% dw, g/100 g on a dry weight basis; nd, not determined.
Chemical composition and structural features of polysaccharides from seaweeds.
| Polysaccharides, Distribution (Function) | Monomeric Composition * (Glycosidic Linkage) | Other Groups Substituents | Other Characteristics |
|---|---|---|---|
| Fucoidans | Type I: L-Fucose (α-1→3) | Sulfated at C-4 (mainly) and C-2 | Molecular weight, degree of branching, sulfation ratio and presence of other monosaccharide (xylose, galactose, uronic acid) variable with the species |
| Agars | Agarose type: β- | Sulfate, methoxy, and pyruvate substituents at C-2, C-6 and C-4 or C-3 | The degree of substitution like sulfation is species specific such as the proportion of agarose and agaropectin. |
| Carrageenans | β- | Sulfate group: only at C-4 of β- | Carrageenans content and type is species specific and depends on ecophysiological factors. There are other less abundant and less commercially relevant types of carrageenans (e.g., θ-, μ-, and β-carrageenans) |
| Ulvans | A3s type: α- | Sulfate groups mainly at C-3 but also at both C-2 and C-3 at rhamnose units | Other sequences were determinate involving xylose and xylose-2-sulfate instead uronic acids residues (U3s and U2′s3s types) and a sequence like A3s but where glucuronic acid occur as branches on C-2 of rhamnose (A2g3s type) |
| Alginates | β- | Each monomer has a | The monomers can be organized into homopolymers or hetero-polymers. The α-1→4 linkages give a bent and rigid chain while the β-1→4 linkage gives a flexible and linear chain. |
| Laminarin or laminaran | Some residues of mannitol and/or uronic acids and occasional β-1→6-linkages in branching points as interchain linkages |
* Monomeric composition of the main chain.
Figure 1Primary structure of a hypothetical protein consisting of all amino acids (1) and the seaweed peptide with potent antioxidant activity (2).
Figure 2Chemical structure of some examples of saturated and unsaturated fatty acids (3–5), acylglycerols (6), glycoglycerolipid (7), phospholipids (8), lipophilic vitamin (9), sterol (10), and carotenoid (11) identified in seaweeds [48,119,120].
Figure 3Distribution of the metabolites isolated from macroalgae per year, adapted from Blunt et al. (2009) and completed with data from the same authors [138,139,142,143,144,145,146,147,148].
Figure 4Chemical structure of secondary metabolites from green algae. (Ac=CH3CO).
Figure 5Chemical structure of secondary metabolites from brown algae.
Figure 6Chemical structure of secondary metabolites from red algae.
Figure 7In vitro mechanism of the action of bioactive compounds isolated from seaweeds.
In vivo pharmacological effects for bioactive compounds found in seaweeds.
| Pharmacological Effects | Type of Seaweed | Ref. |
|---|---|---|
| Anti-inflammatory | Methanolic extracts of the brown seaweeds | [ |
| Red seaweeds | [ | |
| Green seaweed | [ | |
| Antioxidant | Green seaweed | [ |
| Brown alga | [ | |
| Aqueous extract of the green seaweeds | [ | |
| Fucoidan from brown seaweeds | [ | |
| Antitumor | Brown seaweeds | [ |
| Red seaweeds | [ | |
| Hypoglycemic | Brown seaweeds | [ |
| Red seaweed | [ | |
| Hypolipidemic | Brown seaweeds such as | [ |
| Red seaweeds | [ | |
| Green seaweed | [ | |
| Fucoxanthin and Fucoidan from brown seaweeds | [ | |
| Anticoagulant | Brown seaweed | [ |
| Green seaweed | [ |